|Find A Doctor:||Online or call:1-800-247-9580|
Novel Therapies in Pancreatic Cancer to be Introduced at Morristown Medical Center Lecture
MORRISTOWN, NJ, OCTOBER 2011 – Carol G. Simon Cancer Center at Morristown Medical Center presents, “Novel Therapies in Pancreatic Cancer,” on Wednesday, October 26 from 7:00pm to 9:00pm at the Malcolm Forbes Amphitheater, Morristown Medical Center, 100 Madison Avenue, Morristown.
Guest lecturer and colleague, Robert L. Fine, MD, is the Herbert Irving Associate Professor of Medicine and Director of Experimental Therapeutics at the Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center. Dr. Fine specializes in caring for patients with pancreatic cancer, neuroendocrine cancers, untreatable tumors and brain tumors. His expertise lies in creating new experimental therapies for his laboratory and translating them directly to the patient population.
Dr. Fine currently runs seven investigator-initiated clinical trials and has developed a new gene therapy for pancreatic cancer and a P53 peptide therapy for mutant P53 cancers, which have been patented and hold great promise as new treatments for cancer. Additionally, he has developed two separate novel treatments for pancreatic cancer that are currently being tested in his practice at Columbia University and at Morristown Medical Center under lead investigator, Stephen M. Schreibman, M.D.
Preliminary results for Fine’s GTX study show higher response and survival rates than any other study published, as well as the highest successful conversion rate of inoperable pancreatic cancer into operable status. Dr. Fine has published 105 peer-reviewed articles, 220 abstracts, and 18 book chapters. Recently, Dr. Fine was chosen by his peers as one of the top three thought leaders in pancreatic cancer, and is consistently listed in New York Magazine as one of the top doctors in his field.
Dr. Fine received his B.A. and B.S. degrees in Philosophy and BioChemistry and completed medical school at the University of Chicago Pritzker School of Medicine where he graduated with research honors. He conducted his internal medicine training at Stanford University Hospital and his medical oncology fellowship at the National Cancer Institute, National Institutes of Health, where he stayed on faculty for an additional three years in experimental pharmacology. He then spent six years at Duke University Cancer Center as an Assistant Professor of Medicine before joining Columbia University in 1996.
For more information, or to register for this free lecture, call 1-800-247-9580.